阿联酋农场动物药物市场概况、增长、趋势、分析、研究报告(2025-2031)

  • Report Code : TIPRE00041025
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 106
立即购买

阿联酋农场动物药物市场规模预计将从 2024 年的 2098 万美元增至 2031 年的 2595 万美元。预计 2025 年至 2031 年期间该市场的复合年增长率为 3.1%。

阿联酋农场动物药物市场分析

阿联酋农场动物药物市场受到畜牧业、家禽养殖业和动物健康关注的推动。肉类和奶制品等动物基产品的兴起也加速了市场的发展。传统兽药和疫苗、抗生素和生长促进剂等新型生物制剂都对市场产生了影响。政府制定了严格的法规并采用了现代化的养殖技术,以确保食品安全和牲畜健康。随着阿联酋成为贸易枢纽,该地区的畜牧场数量也在不断增加。此外,随着药物配方和动物护理解决方案的创新,市场可以持续发展,并进一步推动市场的发展方向。

阿联酋农场动物药物市场概况

阿联酋的本土畜牧业,尤其是家禽、牛、羊和山羊养殖,正在推动其减少对进口的依赖。这导致对兽药的需求激增,包括抗生素、抗寄生虫药、疫苗和营养补充剂,以确保农场动物的健康和生产力。政府通过国家粮食安全战略等举措和对现代农业基础设施的投资提供的支持进一步刺激了市场。阿联酋气候条件恶劣,养殖方式集约化,因此疾病爆发的风险增加,因此动物预防和治疗药物至关重要。跨国和地区制药公司越来越多地在阿联酋建立联盟或分销网络,以利用这个新兴市场。因此,在创新、政府支持以及对动物福利和食品安全的日益重视的支持下,阿联酋农场动物药物市场预计将经历增长。

定制此报告以满足您的要求

您将获得任何报告的免费定制,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

阿联酋农场动物药物市场:

UAE Farm Animal Drugs Market
  • 获取此报告的顶级关键市场趋势。
    此免费样品将包括数据分析,从市场趋势到估计和预测。

阿联酋农场动物药物市场驱动因素和机遇

 

市场驱动因素:

 

  • 牲畜需求不断增加:

    政府出台了严格的规定并更新了养殖方法,以确保食品安全和牲畜健康。阿联酋市场有望持续增长,因为新的药物配方和动物护理解决方案可能会影响其未来发展方向。
  • 政府举措和法规不断涌现: 

    阿联酋致力于粮食安全和可持续农业的目标体现在政府的举措和法规中。阿联酋政府鼓励本地畜牧业发展,以减少耕地有限的地区对进口食品的依赖。政府正在推行农民补贴、农业基础设施投资以及现代农业技术支持,以鼓励使用高质量的兽药。
  • 动物疾病发病率上升: 

    禽流感和口蹄疫等人畜共患传染病会严重危害家禽和牲畜。例如,近期当地家禽养殖场暴发禽流感疫情,亟需疫苗和抗病毒药物,以避免重大经济损失。 

 

市场机会:

 

  • 采用抗生素替代品:

    由于全球对抗生素耐药性的担忧以及消费者对更安全、无残留的畜产品的需求,抗生素替代品提供了重大机遇。阿联酋的畜牧业,尤其是家禽和奶制品,由于法规和公共卫生需求,面临着减少抗生素使用的压力。阿联酋气候变化与环境部透露,由于益生菌、益生元、有机酸和草药提取物的使用,自2021年以来,牲畜抗生素的使用量减少了20%。
  • 数字健康技术的整合:

    数字健康技术有助于提高牲畜管理的精准度和效率。由于气候干燥且粮食安全需求旺盛,阿联酋对现代农业的兴趣日益浓厚,物联网、人工智能和预测分析技术正越来越多地应用于农业领域。阿联酋气候变化与环境部报告称,2024年,使用智能传感器进行实时健康监测,有助于将疾病造成的损失降低18%。超过25%的商业家禽和奶牛养殖场采用了这些智能传感器。
  • 扩大疫苗接种和预防计划:

    通过疫苗接种和预防项目提高公众意识,牲畜健康和食品安全得到了显著改善。阿联酋注重可持续农业和严格的生物安全措施,加大了对疫苗接种项目的投入,以抗击禽流感和布鲁氏菌病等流行疾病。阿联酋气候变化与环境部报告称,家禽养殖场的疫苗接种覆盖率将从2022年的70%提高到2024年的85%。这有助于将疾病爆发率降低22%。通过为牲畜接种多价疫苗,禽流感在家禽养殖场的传播得到了控制。

阿联酋农场动物药物市场报告细分分析

阿联酋农场动物药物市场细分为不同的细分市场,以便更清晰地了解其运作方式、增长潜力和最新趋势。以下是行业报告中使用的标准细分方法:

按产品类型:

  • 抗感染药物:

    随着阿联酋日益重视粮食安全和动物福利,抗感染药物在应对牛、骆驼、绵羊、山羊和家禽等牲畜传染病方面发挥着关键作用。阿联酋受益于严格的检疫和疫苗接种规程,这推动了对农场动物抗感染药物的需求。  
  • 杀寄生虫剂:

    驱虫剂市场的发展源于对牛、骆驼、羊和家禽等牲畜体内和体外寄生虫的防治需求。这有助于确保粮食安全和动物健康。驱虫剂是动物药物市场的重要组成部分。由于布鲁氏菌病等常见人畜共患疾病的存在,驱虫剂的需求量很大。布鲁氏菌病影响了海湾合作委员会国家17%的全球病例。例如,勃林格殷格翰的Ivomec是一种广泛用于控制牛体内线虫和蜱虫的体内杀虫剂。它可以将生产损失降低高达20%。此外,阿布扎比的动物健康项目等政府举措,以及阿联酋作为硕腾等公司分销中心的作用,也提高了畜牧业的生产力。
  • 抗炎和麻醉药:

    在国家高度重视动物福利和食品安全的背景下,抗炎药物领域对于缓解牛、骆驼、羊和家禽等牲畜的疼痛和炎症至关重要。阿联酋依靠氟尼辛和美洛昔康等非甾体抗炎药 (NSAID) 来治疗奶牛乳腺炎和跛足等疾病,可将生产力损失降低高达 15%。
  • 激素及相关产品:

    激素及相关产品是阿联酋农场动物药物市场的重要组成部分,旨在提高牛、骆驼、羊和家禽等牲畜的繁殖效率和生长速度,这与阿联酋对粮食安全和畜牧业生产力的重视相一致。阿联酋对激素治疗的需求强劲,旨在促进乳制品和肉类的产量。
  • 其他的:

    其他产品涵盖营养补充剂、抗菌剂和诊断剂等专用产品,这些产品对于提高牛、骆驼、羊和家禽等牲畜的健康和生产力至关重要。中国对这些产品的需求日益增长,以应对特定的健康挑战。

按动物类型:

  • 家禽:

    家禽市场是阿联酋农场动物药物市场的基石,其驱动力来自于对家禽产品的高需求以及在快速发展的食品行业中维持禽群健康的需求。阿联酋依赖抗生素、疫苗和饲料添加剂等药物来对抗禽流感和坏死性肠炎等疾病。
  • 牛:

    牛类市场是阿联酋农场动物药物市场的重要组成部分,其驱动力来自于对乳制品和肉类生产的需求,以保障该地区依赖畜牧业的粮食安全。阿联酋使用抗生素、疫苗和激素等药物来控制乳腺炎和口蹄疫等疾病。
  • 马:

    马匹是阿联酋农场动物药物市场的一个重要细分市场,这得益于阿联酋对马术运动、马匹繁育和马术活动的文化热爱。阿联酋需要专门的药物,例如消炎药、镇痛药和疫苗,以治疗马匹的健康问题,例如绞痛和蹄叶炎。
  • 其他的:

    其他部分包括骆驼、山羊、绵羊和其他小众物种等非传统牲畜,这些牲畜对该地区的文化习俗和粮食安全至关重要。阿联酋使用疫苗、杀虫剂和营养补充剂等药物来治疗山羊和骆驼的布鲁氏菌病等疾病。

按给药途径:

  • 口服
  • 外用
  • 肠外
  • 其他的

按分销渠道:

  • 兽医院
  • 兽医诊所
  • 药房和药店
  • 其他的

按国家/地区:

  • 阿联酋

阿联酋农场动物药物市场的增长受到动物疾病发病率上升、政府举措和法规激增以及畜产品需求增加的推动。

 

阿联酋农场动物药物市场报告范围

报告属性细节
2024年的市场规模2098万美元
2031年的市场规模2595万美元
全球复合年增长率(2025-2031)3.1%
史料2021-2023
预测期2025-2031
涵盖的领域按产品类型
  • 抗感染药物
  • 杀寄生虫剂
  • 抗炎药和麻醉药
  • 激素及相关产品
  • 其他的
按动物类型
  • 家禽
  • 其他的
按给药途径
  • 口服
  • 外用
  • 肠外
  • 其他的
按分销渠道
  • 兽医院
  • 兽医诊所
  • 药房和药店
  • 其他的
覆盖地区和国家阿联酋
  • 阿联酋
市场领导者和主要公司简介
  • 硕腾公司
  • 礼来动物保健公司
  • 维克公司
  • 勃林格殷格翰国际有限公司
  • Provet营养
  • VAPCO制造有限公司
  • 海湾药业
  • 德赫拉制药公司
  • 国际化学公司
  • 默克公司

 

阿联酋农场动物药物市场参与者密度:了解其对商业动态的影响

阿联酋农场动物药物市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求的驱动因素包括消费者偏好的不断变化、技术进步以及对产品益处的认知度不断提高。随着需求的增长,企业正在扩展产品线,不断创新以满足消费者需求,并抓住新兴趋势,从而进一步推动市场增长。


UAE Farm Animal Drugs Market

 

  • 获取阿联酋农场动物药物市场主要参与者概览

阿联酋农场动物药物市场份额分析

阿联酋农场动物药品市场正在显著增长。慢性和复杂动物疾病的发病率不断上升,增加了对农场动物药品的需求,以维持牲畜健康。此外,为了提高国内畜牧业生产水平并减少对牲畜进口的依赖,阿联酋对农场动物药品的需求正在激增。以下是阿联酋市场份额和趋势的总结:

 

1.阿联酋

 

  • 市场份额:

    占有相当大的市场份额
  • 关键驱动因素:

  • 畜产品需求不断增长
  • 政府举措和法规不断涌现
  • 动物疾病发病率上升
  • 趋势:

    集约化和数字化农业的增长

阿联酋农场动物药物市场参与者密度:了解其对商业动态的影响

 

市场密度高,竞争激烈

 

由于硕腾、默克和勃林格殷格翰等老牌企业的存在,竞争十分激烈。区域性和利基供应商的加入也加剧了跨地区的竞争格局。

激烈的竞争促使公司通过提供以下产品脱颖而出:

  • 高级产品
  • 产品认证
  • 遵守监管指南

机遇与战略举措

  • 投资生物材料和控释给药系统可以改善治疗效果,并降低农民和兽医的给药复杂性。生物技术和重组疫苗是阿联酋动物疫苗市场增长最快、利润最高的领域。
  • 扩大产品线,包括创新药物、先进疫苗(尤其是重组疫苗)、营养保健品和诊断工具,可提供弹性并满足广泛的客户需求。
  • 利用数字化兽医平台和精准畜牧养殖技术(包括人工智能和区块链工具)可以改善疾病的检测和管理,并在竞争激烈的市场中创造更多差异化优势。采用数字化健康管理系统有助于遵守新的政府法规并提高运营效率。

在阿联酋农场动物药物市场运营的主要公司有:

  1. 硕腾公司
  2. 礼来动物保健公司
  3. 维克公司
  4. 勃林格殷格翰国际有限公司
  5. Provet营养
  6. VAPCO制造有限公司
  7. 海湾药业
  8. 德赫拉制药公司
  9. 国际化学公司
  10. 默克公司

 

免责声明:以上列出的公司没有按任何特定顺序排列。

 

研究过程中分析的其他公司:

  1. 联合兽药工业有限责任公司(UNIVET
  2. MetroVet
  3. Biovac兽药有限公司
  4. Al Alamia兽药制造商
  5. JoinHub海湾制药
  6. Biovac兽药有限公司
  7. 英特拉辛制药
  8. GVC集团
  9. Neopharma 的制药
  10. 因塔斯动物保健公司
  11. Zydus生命科学

阿联酋农场动物药物市场新闻及最新发展

  • 第三种KYOTOBIKEN疫苗在阿联酋上市

    公司推出了三款在阿联酋注册上市的牛疫苗,分别是“KYOTOBIKEN CATTLEWIN-5K”、“BOVINE EPHEMERAL FEVER VACCINE・K-KB”和“KYOTOBIKEN CALFWIN 6 COMBO LIVE VACCINE”。  
  • 阿联酋推出 E-Vet Gate,提供注册兽药产品的完整参考信息

    气候变化与环境部长启动了全球首个兽药专用数字平台E-Vet Gate。此举符合MoCCAE执行2017年第9号联邦法律的授权,该法律规范兽药的处理、交易、营销和流通,旨在遏制这些过程中的非法活动。

阿联酋农场动物药物市场报告覆盖范围和交付成果

《阿联酋农场动物药物市场规模和预测(2021-2031)》报告对以下领域进行了详细的市场分析:

  • 阿联酋农场动物药物市场规模以及涵盖范围内所有关键细分市场的国家层面预测
  • 阿联酋农场动物药物市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST 和 SWOT 分析
  • 阿联酋农场动物药物市场分析涵盖主要市场趋势、国家框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及阿联酋农场动物药物市场的最新发展
  • 详细的公司简介
  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
uae-farm-animal-drugs-market-report-deliverables-img1
uae-farm-animal-drugs-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


What would be the estimated value of the UAE farm animal drugs market by 2031?

The UAE farm animal drugs market is estimated to reach US$ 25.95 million by 2031.

Which product type segment dominated the UAE farm animal drugs market in 2024?

The Parasiticides segment dominated the market in 2024.

Which are the leading players operating in the UAE farm animal drugs market?

Zoetis Inc; Elanco Animal Health Inc; Virbac SA; Boehringer Ingelheim International GmbH; Provet Nutrition; VAPCO Manufacturing CO. Ltd; Gulf Drug; Dechra Pharmaceuticals PLC; Interchemie werken; Merck & Co Inc are among the key players operating in the UAE farm animal drugs market.

What are the factors driving the UAE farm animal drugs market?

Increasing demand for livestock products, surging government initiatives and regulations, and rising prevalence of animal diseases are among the noteworthy factors contributing to the market growth.

What is the expected CAGR of the UAE farm animal drugs market?

The UAE farm animal drugs market is estimated to register a CAGR of 3.1% during the forecast period.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - UAE Farm Animal Drugs Market

  • Zoetis Inc
  • Elanco Animal Health Inc
  • Virbac SA
  • Boehringer Ingelheim International GmbH
  • Provet Nutrition
  • VAPCO Manufacturing CO. Ltd
  • Gulf Drug
  • Dechra Pharmaceuticals PLC
  • Interchemie werken
  • Merck & Co Inc
销售支持
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
与我们聊天
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
ISO Certified Logo

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.